Product
RAY1216
Aliases
[14C] RAY1216
3 clinical trials
2 indications
Indication
pharmacokineticsIndication
COVID-19Clinical trial
Single-center, Open-label, Non-randomized and Single-dose Clinical Trial to Explore the Mass Balance of Oral Suspension of 400mg [14C]RAY1216Status: Completed, Estimated PCD: 2023-11-01
Clinical trial
A Randomized, Double-blind, Placebo-controlled Phase III Clinical Study of RAY1216 Tablets in Patients With Mild to Moderate SARS-CoV-2 InfectionStatus: Completed, Estimated PCD: 2023-01-19
Clinical trial
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics of RAY1216 and the Effect of Food on RAY1216 Pharmacokinetics in Healthy Adult ParticipantsStatus: Completed, Estimated PCD: 2022-08-12